Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia
Principal Investigator
Matthew BennettOverview
Study Start/End
Oct 27, 2020 to Sep 8, 2021Name/Title
Matthew WeiPhone
604-875-5104Email Address
Matthew.Wei@vch.caPurpose of Study
The purpose of this study is to evaluate the safety of etripamil nasal spray in patients with Paroxysmal Supraventricular Tachycardia (PSVT).
Eligibility
Visit ClinicalTrials.gov for more information
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.